ArticleFrontiers in neurology2026
Caloric canal paresis thresholds in relation to vHIT-defined acute unilateral vestibular dysfunction: a retrospective analysis.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Caloric testing and the video head impulse test (vHIT) assess vestibular function at different frequency ranges and provide complementary information in patients with acute vertigo. Although a canal paresis (CP) threshold of 25% is commonly used to define caloric abnormality, interpreting CP values in relation to vHIT-defined unilateral high-frequency vestibular dysfunction remains clinically challenging. Objective: We evaluated how conventional and alternative caloric CP thresholds align with vHIT-defined acute unilateral vestibular dysfunction and sought an interpretive CP threshold best corresponding to vHIT-defined findings. Methods: This retrospective analysis included patients presenting with acute vertigo within 72 h of symptom onset who underwent both caloric testing and vHIT at a tertiary referral center. Patients with clinically suspected benign paroxysmal positional vertigo, Ménière's disease, vestibular migraine, sudden sensorineural hearing loss or labyrinthitis with acute auditory symptoms, central vestibular disorders, bilateral vestibulopathy, or bilateral caloric weakness were excluded. vHIT-defined unilateral dysfunction was based on compatible clinical features and abnormal horizontal-canal vHIT findings indicating unilateral high-frequency vestibulo-ocular reflex dysfunction. Receiver operating characteristic (ROC) analysis examined how caloric CP values corresponded to this classification. Results: Of 1,634 eligible patients, 145 met criteria for vHIT-defined unilateral dysfunction. The symptomatic vHIT-normal comparison group comprised 1,489 patients without a final diagnosis of definite peripheral or central vestibular disease, although some had isolated caloric abnormalities. The conventional 25% CP threshold showed high sensitivity for the vHIT-based classification but classified a larger number of symptomatic vHIT-normal patients as CP abnormal. ROC analysis identified an approximately 30% CP threshold (Youden's index) with sensitivity 0.945 and specificity 0.867. This threshold reduced vHIT-discordant caloric abnormal classifications compared with 25% while maintaining close correspondence with the vHIT-defined classification. Conclusion: In patients evaluated within 72 h of acute vertigo onset, a CP threshold of approximately 30% showed the closest correspondence with vHIT-defined unilateral high-frequency vestibular dysfunction. It should be interpreted as a practical benchmark for interpreting caloric CP in relation to vHIT findings, not as an independent diagnostic criterion for AUVP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.